ProtonDx is revolutionising the world of rapid, molecular testing at point of need. Our goal is to ensure specific viral detection diagnosis uncertainty is a thing of the past. Our expertise is in cutting edge electronics, molecular biology, and machine learning which we have blended together to create novel portable connected devices. Powered by highly sensitive LAMP technology, these are providing new robust methods to identify multiple pathogens, quickly and accurately. This approach puts us at the forefront in the global fight against antimicrobial resistance.
Spun out of Imperial College London in March 2020, ProtonDx ambition is to ensure tests can be conducted quickly, accurately and cost effectively, wherever and whenever they are needed throughout the world so that all can benefit from advances in technology.
Our innovative lab on a chip technology has already received many awards including the 2020 IEEE CASS COVID 19 Entrepreneur’s award, the IEEE Sensors Technical Achievement award, IET Mike Sergeant Achievement Medal, Rosetrees Trust Interdisciplinary Prize, Wellcome Trust Innovator Award, two Imperial Techcelerate Awards, MedTech SuperConnector Award, and various other IEEE awards.


Health Diagnostics

Life Sciences

Medical Devices

ProtonDx

ProtonDx's headquarters in London, United Kingdom

Description

People (6)

Matthew Cavuto

Nick Moser

Sohail Mirza

Jesus Rodriguez Manzano

Rod Rhys Jones

Danny Filer

Jobs